What is the recommended cephalexin dosing regimen for an adult outpatient with methicillin‑susceptible Staphylococcus aureus (MSSA) pneumonia and normal renal function?

Cephalexin Dosing for MSSA Pneumonia

For adult outpatients with confirmed MSSA pneumonia and normal renal function, cephalexin 75-100 mg/kg/day divided into 3-4 doses (typically 500 mg every 6-8 hours) is the recommended oral regimen, though this is primarily supported by pediatric guidelines and should only be used after appropriate initial parenteral therapy or in carefully selected mild cases.

Context and Important Limitations

The evidence base for cephalexin in MSSA pneumonia is notably limited for adults:

• Pediatric guidelines specifically recommend oral cephalexin (75-100 mg/kg/day in 3-4 doses) for MSSA pneumonia in children as step-down or mild infection therapy 1
• Adult hospital-acquired pneumonia guidelines (2016) do not include cephalexin in their empiric or definitive treatment recommendations 2
• For proven MSSA in hospitalized adults, oxacillin, nafcillin, or cefazolin are preferred agents 2

Recommended Dosing Approach

For Adults (Extrapolated from Pediatric Data and FDA Labeling)

Standard dosing:

• 500 mg orally every 6 hours (2 grams/day total) 3
• For more severe infections: 500 mg every 6 hours or up to 1 gram every 6 hours (up to 4 grams/day maximum) 3

Duration:

• Minimum 10-14 days for pneumonia, though specific duration data for MSSA pneumonia are lacking 3

Critical Clinical Considerations

When cephalexin may be appropriate:

• Step-down therapy after initial parenteral treatment with cefazolin (150 mg/kg/day IV) or oxacillin 1
• Mild, uncomplicated MSSA pneumonia in carefully selected outpatients without high-risk features 1
• Completion of therapy for MSSA bacteremic infections after adequate IV therapy (at least 3 weeks), as demonstrated in vertebral osteomyelitis studies 4

When cephalexin is NOT appropriate:

• Empiric therapy for hospital-acquired pneumonia—use piperacillin-tazobactam, cefepime, levofloxacin, imipenem, or meropenem instead 2
• Severe pneumonia requiring hospitalization—use IV cefazolin, oxacillin, or nafcillin 2
• Patients with risk factors for treatment failure (septic shock, need for ventilatory support) 2

Pharmacokinetic Considerations

Absorption and distribution:

• Cephalexin is rapidly and completely absorbed from the upper intestine, achieving peak levels 1 hour after dosing 5
• 70-100% is excreted unchanged in urine within 6-8 hours, achieving excellent urinary concentrations but limited tissue penetration 5
• Does not penetrate well into host cells or achieve high tissue concentrations, which may limit efficacy in pneumonia 5

Renal dosing adjustments:

• For creatinine clearance <30 mL/min, reduce dose proportionally to renal function 5
• Standard adult dosing assumes normal renal function 3

Alternative Preferred Agents for MSSA Pneumonia

For hospitalized adults with proven MSSA pneumonia:

• IV cefazolin, oxacillin, or nafcillin are strongly preferred over cephalexin 2
• Clindamycin 40 mg/kg/day IV (if susceptible) is an alternative 1, 6

For oral step-down therapy:

• Clindamycin 30-40 mg/kg/day orally in 3-4 divided doses (adult: typically 300-450 mg every 6-8 hours) may be preferred over cephalexin for serious infections 1, 6

Common Pitfalls

• Avoid using cephalexin as monotherapy for severe or complicated MSSA pneumonia—it lacks robust adult clinical trial data for this indication 2
• Do not assume cephalexin equivalence to IV cefazolin—oral bioavailability and tissue penetration differ significantly 5
• Ensure adequate duration of initial IV therapy (typically ≥3 weeks for bacteremic infections) before transitioning to oral cephalexin 4
• Monitor for treatment failure, particularly in patients with abscess formation or complicated pneumonia 4